Cargando…
Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
Recent data on the application of dendritic cells (DCs) as anti-tumor vaccines has shown their great potential in therapy and prophylaxis of cancer. Here we report on a comparison of two treatment schemes with DCs that display the models of prophylactic and therapeutic vaccination using three differ...
Autores principales: | Markov, Oleg V., Mironova, Nadezhda L., Sennikov, Sergey V., Vlassov, Valentin V., Zenkova, Marina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556596/ https://www.ncbi.nlm.nih.gov/pubmed/26325576 http://dx.doi.org/10.1371/journal.pone.0136911 |
Ejemplares similares
-
Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials
por: Markov, O. V., et al.
Publicado: (2017) -
Human Recombinant DNase I (Pulmozyme(®)) Inhibits Lung Metastases in Murine Metastatic B16 Melanoma Model That Correlates with Restoration of the DNase Activity and the Decrease SINE/LINE and c-Myc Fragments in Blood Cell-Free DNA
por: Alekseeva, Ludmila, et al.
Publicado: (2021) -
Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells
por: Markov, O. V., et al.
Publicado: (2016) -
MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2013) -
The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2017)